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Background. The aim of this study was to use various theoretical methods derived from the Linear Quadratic (LQ) 
model to calculate the effects of number of subfractions, time intervals between subfractions, dose per subfraction, 
and overall fraction time on the cells’ survival. Comparison of the results with experimental outcomes of melanoma 
and breast adenocarcinoma cells was also performed. Finally, the best matched method with experimental out-
comes is introduced as the most accurate method in predicting the cell response.
Materials and methods. The most widely used theoretical methods in the literature, presented by Keall et al., 
Brenner, and Mu et al., were used to calculate the cells’ survival following radiotherapy with different treatment 
schemes. The overall treatment times were ranged from 15 to 240 minutes. To investigate the effects of number of 
subfractions and dose per subfraction, the cells’ survival after different treatment delivery scenarios were calculated 
through fixed overall treatment times of 30, 60 and 240 minutes. The experimental tests were done for dose of 4 Gy. 
The results were compared with those of the theoretical outcomes.
Results. The most affective parameter on the cells’ survival was the overall treatment time. However, the number 
of subfractions per fractions was another effecting parameter in the theoretical models. This parameter showed no 
significant effect on the cells’ survival in experimental schemes. The variations in number of subfractions per each frac-
tion showed different results on the cells’ survival, calculated by Keall et al. and Brenner methods (P<0.05).
Conclusions. Mu et al. method can predict the cells’ survival following fractionation radiotherapy more accurately 
than the other models. Using Mu et al. method, as an accurate and simple method to predict the cell response after 
fractionation radiotherapy, is suggested for clinical applications.
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Introduction
Radiotherapy is one of the main procedures of 
cancer treatment. The goal of radiotherapy is to de-
liver as much dose to the tumor site while keeping 
the dose to the surrounding normal tissues as low 
as possible.1, 2 In radiotherapy, in addition to the 
conventional techniques used in clinical practice, 
some state of the art specialized techniques such 
as Intensity Modulated Radiation Therapy (IMRT), 
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Respiratory-Gated, stereotactic, and Image Guide 
Radiotherapy (IGRT) have also been developed.3-7 
These modern techniques optimize the radio-
therapy dose distribution since they include more 
segments in the radiation field which are usu-
ally shaped using more complicated equipment.3-7 
These techniques enhance tumor local control and 
have lower radiation-induced toxicities in normal 
organs around the tumor compared to conven-
tional techniques. Moreover, they vary in the dose 
delivery due to using more subfractions per each 
treatment fraction, different treatment times be-
tween subfractions, and the prolonged treatment 
time of one fraction.4,8-15
The radiobiological efficiency of these tech-
niques might be different from conventional one 
mainly due to the repair of sublethal damages.8-16 
However, the rate and the mechanism of repair is a 
complicated function of different parameters such 
as dose per fraction, dose rate, repairs half time, 
and state and nature of the organs of interest (i.e. 
α/β ratio of the organ).8-16
To predict the results of different radiation de-
livery procedures on the cells’ survival, the basic 
theoretical model is the incomplete repair model 
of Thames17 generalized to multiple fractions by 
Nilsson et al.18 that is a developed form of Linear 
Quadratic (LQ) model. Some studies have inves-
tigated the effects of prolonged time of radiation 
delivery on the survival of some cell lines and com-
pared the results with theoretical methods derived 
from the LQ model.8-15
Although these theoretical methods are all de-
rived from the basic LQ model, however, the rate 
of agreement between their results in researches 
and experiments was significantly different for di-
verse dose schedules.8,9,19-21
Therefore, more investigations are needed in 
order to evaluate the effect of various treatment 
factors on the cells’ survival. In addition, it seems 
beneficial to compare the results of these methods 
theoretically and experimentally in order to find 
the best method that can be used to predict the 
cells’ survival after different fractionation radio-
therapy schemes.
The aim of this study was to compare various 
theoretical methods widely used in the litera-
ture8,9,19-21 to estimate the effects of number of sub-
fractions, time intervals between subfractions, dose 
per subfraction, and overall fraction time on the 
F10B16 skin melanoma and 4T1 breast adenocar-
cinoma cells’ survival. Comparison of the results 
with experimental outcomes of melanoma and 
breast adenocarcinoma cells was also performed. 
Moreover, in this work, the best matched method 
with experimental outcomes is introduced as the 
most accurate one in predicting the cell response in 
fractionation radiotherapy.
Materials and methods 
Theoretical methods
Three methods of calculation derived from LQ 
model, presented by Keall et al., Brenner, and Mu et 
al.8,9,19-21, were compared to investigate the effect of 
different dose schemes (dose per subfraction, time 
intervals between subfractions, total treatment 
time of each fraction) on the survival of F10B16 
skin melanoma and 4T1 breast adenocarcinoma 
cells. The basic idea of these methods is based on 
the completed LQ model as:
 [1]
Which is a developed form of the basic LQ mod-
el:
 [2]
Where α and β are cell parameters, D is the total 
dose delivered to the cells, S is the survival fraction 
of cells, and G parameter is defined in intermittent 
radiotherapy to investigate the effect of subfrac-
tions. The G parameter has been formulated differ-
ently by various investigators.8,9,19-21
The first method (method I) was presented by 
Keall et al.9 They have experimentally and theoreti-
cally investigated the temporal effects of respirato-
ry-gated and IMRT treatment delivery for dose of 
2 Gy and in the total treatment times of 1.67 min 
(in conformal radiotherapy) to 15 min (in gated 
IMRT) on the cells’ survival. Keall et al. have used 
a simplified form of G to predict the cells’ survival 
and have compared the outcomes with experi-
mental results.9 They have assumed negligible cell 
proliferation and unchanging radiosensitivity.9 
According to Keall et al. study, the G parameter is 
calculated as9: 
 [3]
Where
 [4]
In this method, μ is the rate constant for repair 
of sublethal damages, n is the number of subfrac-
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tions, τ is the time of exposure and Δt is the time 
between subfractions. This method assumes a 
constant value for both exposure time (t) and the 
time between exposures (Δt).9 Keall et al. results 
showed no significant difference between the ex-
perimental observations and theoretical calcula-
tions.9 Moreover, this method indicated a good 
agreement with experimental results for the total 
dose of 2 Gy.9
The second method (method II) was utilized by 
Brenner.20 This method was also proposed in some 
review papers.19,21 Brenner has simplified the LQ 
model and experimentally and theoretically inves-
tigated the temporal effects of fractionation treat-
ment delivery on in vitro survival.20
In Brenner method, the G factor accounts for 
fraction protection and acts on the quadratic com-
ponent as follow20:
 [5]
In this method, the used parameters are the same 
as Keall et al. method.9 As this formula (equation 5) 
shows, the effects of time intervals between sub-
fractions are ignored, however, Brenner has con-
firmed that there was a good agreement between 
the outcomes of this formula and the experimental 
results.20 Therefore, it has been proposed that, this 
formula can be used to calculate the cell response 
after prolonged treatment delivery.20 In addition, 
this method can be employed to calculate the pro-
traction effects in a single fractionation delivered 
at a constant rate, splitting dose, multi-fraction ir-
radiation protocols and continuous low dose rates 
radiotherapy such as brachytherapy.20
The third theoretical method (method III) was 
reported by Mu et al.8 In Mu et al. study, the G pa-
rameter is defined as below8: 
 [6]
All the used parameters in this method are ex-
plained above. In this method, it is assumed that 
there is no recovery during actual irradiations but 
rather during the time between subfactions.8
Cell culture and assay
The cells were cultured in plastic flasks at 37°C in 
a humidified atmosphere of 50 mL/L CO2 and 95% 
air with the RPMI1640 medium containing 10-15% 
fetal calf serum (FCS or FBS) with 100 U/mL peni-
cillin and 100 μg/mL streptomycin.
Due to tree shaped structure of these cell lines, 
complexity of counting their colonies, and sig-
nificant number of samples used in this study, 
an automated and faster assay method was used. 
Therefore, instead of the clonogenic assay, the mul-
ti 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetra-
zoliumbromide (MTT) assay was used. This 
method was offered in other similar researches22-24 
and all the details of experimental procedure are 
published in papers by our team for these two cell 
lines (F10B16 melanoma and 4T1 breast adenocar-
cinoma) of interest.25,26
Theoretical schemes
In this paper, α and β parameters were calculated 
using the basic LQ model (equation 2). Hence, the 
cell survival fractions (S) following doses of 2, 4, 6, 
8 and 10 Gy were experimentally determined for 
both melanoma and breast adenocarcinoma cells 
and then inserted in the basic formula of the LQ 
model. Using the S and D parameters and insert-
ing them in the mentioned formula, the survival 
curves of cell lines were drawn and α and β param-
eters were derived using the MATLAB software 
(Version 7.11, R2010b, MathWorks, USA).8,25
In order to determine the time constant for re-
pair of sublethal damage (T1/2), the cells were ex-
posed in two fractions with different time intervals 
between the fractions. Then, the surviving fraction 
was plotted against the time between fractions and 
finally the half value of sublethal damage repair 
was investigated.8,25
All the cell’s parameters for both cell lines of in-
terest, used in this study, are illustrated in Table 1. 
Different treatment schemes were designed 
in order to investigate the effects of the most im-
portant radiobiological parameters including; the 
number of subfractions, time intervals between 
subfractions, subfraction doses, and overall treat-
ment time, in complex radiotherapy practices.
To investigate the effect of total treatment time, 
the survival fraction (SF) were calculated for dose 
of 2, 4 and 6 Gy in two subfractions of 1, 2 and 3 
Gy, respectively. The overall treatment times were 
TABLE 1. The F10B16 and 4T1 cell parameters as input data for the used models
Symbols 
(unit) Definitions F10B16 4T1 
α (Gy-1) Linear parameter of LQ model 0.0956 0.0424 
β (Gy-2) Quadratic parameter of LQ model 0.0177 0.0399 
T1/2 (hour) Half time of sublethal repair 0.524±0.035 0.344±0.015 
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ranged from 15 to 240 minutes. Although, total 
treatment time in complicated radiotherapy is 
about 1 hour and longer treatment time is not prac-
tical, however, we followed the investigations for 
up to 4 hours to determine comprehensive results 
and investigate the ability of the developed models 
to predict the cells’ survival.
To investigate the effects of increasing the num-
ber of subfractions and dose per subfraction, the 
survival was calculated for total dose of 2, 4 and 6 
Gy in 4 and 8 subfractions as follow: 4 fractions of 
0.5 Gy and 8 fractions of 0.25 Gy (both for a total 
dose of 2 Gy), 4 fractions of 1 Gy and 8 fractions of 
0.5 Gy (both for a total dose of 4 Gy) and 4 fractions 
of 1.25 Gy and 8 fractions of 0.75 Gy (both for a to-
tal dose of 6 Gy). They all delivered through fixed 
overall treatment times of 30, 60 and 240 minutes.
It should be noted that the theoretical methods 
presented by Keall et al., Brenner, and Mu et al. can 
be used in predicting survival in fractionation radi-
otherapy and some of them have flaw in predicting 
survival when the dose is delivered continuously 
in one fraction.8,9 Therefore, in this work, the basic 
LQ model (equation 2) was used to predict the cell 
survival following continuous dose delivery. 
Experimental schemes
The cells were picked out from the flasks when 
they reached to linear phase of exponential grow in 
the day before irradiation and were put in 96 well 
plates with density of 1000 cells in each well.22-25 
There were 7 samples for each experiment and, to 
avoid the variability inherent to the assay used, all 
tests were performed for 3 independent experi-
ments. A Co-60 source with a dose rate of 0.81 Gy/
min was used for irradiation. The ionizing radia-
tion was delivered in a 25×25 cm2 field size. All ir-
radiations were performed at a distance of 20 cm 
between the radiation sources and plate. 
To measure the absorbed dose rate of the 
Cobalt-60 beam, a Farmer-type ionization chamber 
with a standard 60Co buildup cap, and positioned 
in air using a customized stand, was used. “For 
traceability to international standards, the ioniza-
tion chamber was calibrated in comparison with 
the response of the Secondary Standard Dosimetry 
Laboratory (SSDL, Karaj Complex, Atomic Energy 
Organization of Iran) reference and working stand-
ard ionization chambers in the 60Co gamma ray 
beam of a teletherapy unit. All of the SSDL ioniza-
tion chambers used for calibrations are themselves 
calibrated at the International Atomic Energy 
Agency (IAEA) dosimetry laboratory”.27
To design the experimental tests, firstly, contin-
uous radiation with doses of 2, 4 and 6 Gy, similar 
to conventional radiotherapy techniques, were de-
livered to the cells. Next, to investigate the effect 
of overall treatment time on the cells’ survival, the 
same as the theoretical schedules, 6 groups from 
both of the studied cell lines were exposed to 2, 4 
and 6 Gy in two subfractions with dose of 1, 2 and 3 
Gy, respectively. In this step, the overall treatment 
time was 15 to 240 minutes. Then, to simulate the 
effects of the number of subfractions as well as dose 
per subfraction, 4 and 8 subfractions with dose of 1 
and 0.5 Gy, respectively (total dose of 4 Gy), were 
delivered to the cells at overall treatment times of 
30, 60 and 240 minute. After that, the results were 
compared with those of continuous radiation.
It should be noted that, although the conven-
tional treatment dose used in clinical situation is 
approximately 2 Gy per fraction8,9, however, the 
A
B
FIGURE 1. The survival curves of the (A) melanoma F10B16 and (B) breast 
adenocarcinoma 4T1 cell lines (R2 is a statistical measure of how close the data are 
to the fitted regression curve. It is also known as the coefficient of determination).
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effect of this low level of dose on the cell culture 
environment was negligible for the two cell lines of 
interest (Figure 1), and consequently the dose of 4 
Gy was used in this experiment.
Statistical analysis
Statistical analysis was performed using the SPSS 
software version 14 (SPSS, Inc., Chicago, IL, USA). 
To assess the effects of different irradiation proto-
cols, the analysis of variance (ANOVA) was used. A 
significant level of 0.05 was considered to the tests.
Results
Figure 1 illustrates the survival curves for the two 
cells of interest as well as the calculated α and β 
parameters. Figures 2, gives the survival of the cells 
in continuous radiation with dose of 2, 4 and 6 Gy 
and also in fractionation delivery in two subfrac-
tions of 1, 2 and 3 Gy, during the overall treatment 
time of 15 to 240 minute. Figures 3 to 5, show the 
predicted survival using the theoretical methods of 
Keall et al., Brenner, and Mu et al., as well as the 
experimental results. For a total dose of 2 Gy and 
all irradiation times in both two cell lines of inter-
est (4T1 and F10B16), there was no significant dif-
ference (P<0.05) between the calculated survival by 
the three used methods (Figure 3).
For a dose of 4 Gy, there was no significant dif-
ference (P<0.05) between survivals calculated by 
three methods in total treatment time of up to 60 
FIGURE 2. The survival fraction of F10B16 and 4T1 cells in dose levels of 2, 4 
and 6 Gy delivered continuously and in two subfractions of 1, 2 and 3 Gy, 
respectively, for overall treatment time of 15 to 240 minutes.
TABLE 2. Experimental and calculated survival using method III for total dose of 4 Gy
Survival fractions of F10B16 and 4T1 cells
Experimental calculations Theoretical calculations
Number of 
subfractions×dose (Gy)
Total treatment 
time (min) F10b16 4T1 F10b16 4T1
0×0 0 1 1 1 1
1×4 5 0.518±0.019 0.459±0.017 0.513±0.038 0.445±0.012
2×2 15 0.535±0.027 0.506±0.018 0.534±0.036 0.505±0.048
2×2 30 0.549±0.017 0.547±0.018 0.550±0.023 0.545±0.019
2×2 60 0.570±0.016 0.588±0.017 0.569±0.029 0.587±0.042
2×2 120 0.586±0.016 0.609±0.018 0.585±0.019 0.609±0.027
2×2 180 0.590±0.018 0.612±0.019 0.590±0.054 0.612±0.038
2×2 240 0.591±0.029 0.613±0.016 0.591±0.024 0.613±0.029
4×1 30 0.546±0.026 0.546±0.017 0.542±0.038 0.529±0.035
8×0.5 30 0.549±0.015 0.547±0.026 0.540±0.034 0.523±0.043
4×1 60 0.570±0.017 0.585±0.017 0.567±0.047 0.595±0.047
8×0.5 60 0.570±0.016 0.583±0.008 0.564±0.028 0.589±0.038
4×1 240 0.598±0.018 0.653±0.027 0.622±0.024 0.706±0.038
8×0.5 240 0.607±0.008 0.674±0.008 0.627±0.023 0.732±0.042
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minute (Figure 4). After 60 minute, for the F1B16 
cells, there was a significant difference between 
method I and the other two methods. While in the 
treatment time less than 240 minute there was no 
significant difference between methods I and III 
(P<0.05). For the 4T1 cells, there were significant 
differences (P<0.05) in calculated survival between 
method I and the two other methods. Considering 
total treatment time, these variations increased 
considerably after 60 minute. Small differences ob-
served between methods II and III in groups with 4 
or 8 subfractions (Figure 4).
For a total dose of 6 Gy, the results of calcula-
tions for the F10B16 cells were the same as dose 
of 4 Gy (Figure 5). For the 4T1 cells, a significant 
difference between the used methods observed, es-
pecially between the method I and the other two 
methods (Figure 5).
These results showed that, when the total treat-
ment time increased, the survival of both two cell 
lines increased significantly according to all three 
methods.
Increasing the number of subfractions showed 
different results according to the used methods. 
According to the method I, increasing the num-
ber of subfractions in a fixed total treatment time 
reduced the survival in all three doses of 2, 4 and 6 
Gy. The predicted survival according to the method 
II did not show any significant difference (P<0.05) 
due to the variations in number of subfractions.
The calculated survival by the method III for 
F10B16 melanoma cell line, showed a significant 
decrease by increasing the number of subfractions 
from 2 to 4 and 4 to 8, for total dose of 2, 4 and 6 
Gy and both treatment times of 30 and 60 minute. 
While, for the 240 minute treatment time, increas-
ing the number of subfractions increased the sur-
vival of the cells (Figures 3 to 5).
For 4T1 cell line, increasing the number of sub-
fractions decreased the survival of the cells in 30 
minute treatment time. For the total treatment time 
of 60 minute, increasing the number of subfrac-
tions from 2 to 4 fractions enhanced the survival 
of the cells, whereas, increasing the subfractions 
to 8 declined the cells survival. For the 240 minute 
treatment time, increasing the number of subfrac-
tions raised the cells survival (Figures 3 to 5).
Considering the three used methods, differ-
ences between the exposed groups to 2 Gy was not 
significant for the F10B16 cells and was negligible 
for 4T1 cells. Therefore, to investigate the effects of 
number of subfractions and dose per subfraction 
in experimental investigations, a total dose of 4 
Gy was used. The results of this experiment were 
FIGURE 3. The survival fraction predicted by the used methods for F10B16 melanoma 
(A) and 4T1 breast adenocarcinoma (B) cell lines in different fraction numbers, dose 
per fractions, and total treatment times, for dose of 2 Gy.
A
B
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assessed in 2, 4 and 8 fractions during treatment 
times of 30, 60 and 240 min, for both F10B16 and 
4T1 cell lines.
Comparisons between the experimental results 
with those calculated by the three used methods 
showed that experimental results were in a good 
agreement with method III. The results of experi-
mental investigations and the calculated survival 
by the method III are shown in Table 2.
The results showed that, in a fixed overall treat-
ment time, there was no statistical significant dif-
ference (P<0.05) between the irradiated groups 
in different subfractions. Considering the overall 
treatment time, there was an agreement between 
experimental results and those predicted by the 
method III for the irradiated cells in total treatment 
time of 1 h, as opposed to the 4 h irradiated group.
Discussion
Recently, some researchers have shown the ef-
fect of prolonged dose delivery time on the cell 
survivals.8-15 In this regard, several models have 
been offered to predict the effects of variations in 
the treatment procedures on the cells survival.8,9,20 
One of these models is the developed LQ model 
by Thames and Dale.17 However, different theoreti-
cal methods have been derived from this model in 
some researches in order to predict the survival of 
cells after prolonged dose delivery schemes.8,9,10,19 
As stated earlier, these researches have just inves-
tigated the effect of total treatment time and have 
not considered the effects of number of subfrac-
tions, dose per subfarction and the time intervals 
between subfractions in detail.
Therefore, more investigations were needed in 
order to determine the effect of different treatment 
factors on cells’ survival. In addition, it seems use-
ful to compare the results of these methods theo-
retically and experimentally in order to find the 
best method for clinical application in fractionation 
radiotherapy.
In this study, three calculation methods derived 
from the basic LQ model proposed in different re-
searches8,9,20 were used to evaluate the effects of 
different parameters such as total treatment time, 
number of subfractions, and subfractions interval 
on survival of cell lines with constant α, β and μ 
parameters. Then, the results were compared with 
experimental outcomes of F10B16 skin melanoma 
and 4T1 breast adenocarcinoma cells.
Comparison between the results of the used 
three methods with those of experimental results 
FIGURE 4. The survival fraction predicted by the used methods as well as the 
experimental results for F10B16 melanoma (A) and 4T1 breast adenocarcinoma (B) 
cell lines in different fraction numbers, dose per fractions, and total treatment times, 
for dose of 4 Gy.
A
B
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showed that method III (Mu et al. model) was in a 
better agreement with experimental outcomes. Mu 
et al. proposed a method to calculate the effect of 
prolonged treatment time on the Chinese hamster 
fibroblasts (V79-379-A) cells’ survival for total treat-
ment dose of 2 and 8 Gy. They have shown that, 
there is a good agreement between experimental 
and theoretical results for the total dose of 2 Gy and 
treatment time below 1 hour. While in our study, 
different mathematical methods presented by Keall 
et al., Brenner and Mu et al., were used to calculate 
the cells’ survival after different treatment schemes 
such as 2, 4, and 6 Gy continuous dose in two sub-
fractions with dose of 1, 2, and 3 Gy, respectively. 
In this work, to investigate the effects of the number 
of subfractions and dose per subfraction, the cells’ 
survival after total doses of 2 Gy (4 subfractions of 
0. 5 Gy and 8 subfractions of 0.25 Gy), 4 Gy (4 sub-
fractions of 1 Gy and 8 subfractions of 0.5 Gy), 6 Gy 
(4 subfractions of 1.25 Gy and 8 subfractions of 0.75 
Gy) were calculated through fixed overall treat-
ment times of 30, 60 and 240 minutes. 
Considering the method III investigations in pre-
dicting the F10B16 cells survival (T1/2 = 30 minute), 
it is expected that increasing the number of subfrac-
tions reduced the survival, in total treatment times 
of 30 and 60 minute. The reason was due to the 
repair of sublethal damages. For all defined sub-
fractions (2, 4 and 8), the intervals between subfrac-
tions was lower than T1/2, therefore, after the first 
irradiation there was not enough time for the cells 
to repair their sublethal damages, hence the sur-
vival reduced. This effect was found for 4T1 cells in 
total treatment time of 30 minute. However, for the 
60 minute treatment time, considering the T1/2 of 
about 20 minute (significantly lower than F10B16) 
the time between 4 subfractions was higher than 
the repair time, and therefore, after irradiation in 
the first subfraction the damages were repaired be-
fore starting the next exposure, consequently the 
survival increased. However, for the 8 subfractions 
in 60 minute treatment time, the results were the 
same as before. These explanations can justify the 
behavior of the used both two cell lines in 240 min-
ute treatment time, too. Therefore, the survival of 
cells increased for this total treatment time.
Experimental results showed that increasing 
the total treatment time, similarly occurred in new 
complicated methods such as IMRT, increased the 
cell survival in both cell lines and all three total 
dose of 2, 4 and 6 Gy in up to 2 hour treatment time. 
However, the extent of this effect was not consid-
erable for F10B16 cells with shorter T1/2, and was 
negligible for the dose of 2 Gy for this cell line.
FIGURE 5. The survival fraction predicted by the used methods for F10B16 melanoma 
(A) and 4T1 breast adenocarcinoma (B) cell lines in different fraction numbers, dose 
per fractions, and total treatment times, for dose of 6 Gy.
A
B
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Moreover, the results of this research confirmed 
that a cell with lower α/β ratio is considered to 
have a greater ability to undergo sublethal damage 
repair. The rate of sublethal damage repair may be 
represented by T1/2; therefore, cells with a shorter 
T1/2 have more repairs. In addition, the survival 
of 4T1 cell line with lower α/β and T1/2 was dra-
matically different than the F10B16, when the time 
interval between subfractions increased.
In total treatment time of 4 hours, both theoreti-
cal and experimental results showed an increase in 
survival with fractionated irradiation.
Some studies have been performed to investigate 
the ability of LQ model in predicting the survival 
in low dose levels (< 1 Gy).21,28,29 Cherubini et al. and 
Jones et al. explained that in low doses (less than 1 
Gy) the LQ model cannot predict the cell survival 
accurately.28,21 While, Smith et al. claimed that the 
LQ model calculates the survival precisely in such 
low doses.29 Brenner has shown that in total dose 
of 2 to 15 Gy, the LQ model can accurately predict 
the survival in in-vitro and in-vivo conditions.20 In 
this study, in line with Brenner, the results suggest 
that, in fractionation radiotherapy, the developed 
LQ model can potentially reach close agreement 
with reality in total treatment dose of 2 to 4 Gy.
Compared with other studies, using small sub-
fractions of 0.25–0.5 Gy, Marples et al.30, and Mu et 
al.8 investigated the phenomenon of hypersensitiv-
ity to low doses per fraction. Marples et al. showed 
that, this would lead to a more effective cell killing 
than predicated by the LQ model.30 While Mu et al. 
study showed that there was no evidence for such 
effect since it should have resulted in lower surviv-
al than expected and not higher.8 They explained 
that this effect is perhaps because of the effective 
dose rate in each fraction which is too high to 
avoid activating a possible repair.8 However, in our 
study which lower dose rate was used, cell killing 
reached close agreement to the amount predicted 
by the LQ model that is in an agreement with the 
Marples et al. result. The factors that influence the 
dose rate are radical recombination and sublethal 
damage repair.30 It should be noted that, at the dose 
levels and dose rates encountered in radiotherapy, 
the effect of radical recombination on cell killing is 
negligible.31 Ling et al.32 and Michaels et al.33 have 
compared the survival of CHO cells at dose rates 
of 0.6 Gy/min from a Co-60 unit, and their results 
showed that the obtained survival curves were ex-
actly the same with up to 15 Gy/min dose rates. 
Hence, based on the results of our study and com-
parisons with other works, an idea to reduce the 
effect of fractionation or prolonged treatment time 
is using higher dose rates or more treatment dose 
in one fraction. 
In other work by Keall et al.9, they have shown 
that both respiratory gating and IMRT delivery 
will decrease survival compared with continuous 
delivery of the same dose in the same overall time. 
Therefore, for a given treatment time, delivery 
method is another factor affecting the cell survival.
Conclusions
According to presented experimental and theo-
retical results, in treatment of tumors in radio-
therapy by new complicated methods, this should 
be noted that exceeding the treatment time will 
increase the survival of tumor cells and may de-
crease tumor control. Increasing the number of 
subfractions in a course of treatment could reduce 
the cell survivals if the fractions time interval be 
lower than the repair time of sublethal damages. 
Although, this parameter has a negligible effect on 
the survival of the cell lines of interest in our ex-
perimental study, this factor can be considered in 
compensating the increase in cell survival due to 
the time prolongation.
It seems appropriate to use the method pro-
posed by Mu et al. to predict the cell response fol-
lowing fractionation radiotherapy, especially in 
new fractionation radiotherapy procedures with 
more number of subfractions and with prolonged 
total treatment times. This method can simply and 
accurately determine the cell survival after each 
radiotherapy assessment and can be used to cal-
culate the compensating dose for these treatment 
schedules. Although the effect of fractionation 
dose delivery is negligible for one session (with 
dose of 2 Gy), and it seems that there is no need 
to compensate these effect, but it can be important 
for a radiotherapy period (30 or 35 session with 2 
Gy in each fraction) because of the cumulative ef-
fect of dose.
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